{"id":23717,"date":"2024-02-28T13:58:00","date_gmt":"2024-02-28T13:58:00","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=23717"},"modified":"2024-02-28T13:58:29","modified_gmt":"2024-02-28T13:58:29","slug":"ingiltere-kanser-tedavisi-icin-bekleme-sureleri-konusunda-diger-ulkelerin-gerisinde-kaldi","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/ingiltere-kanser-tedavisi-icin-bekleme-sureleri-konusunda-diger-ulkelerin-gerisinde-kaldi\/","title":{"rendered":"\u0130ngiltere kanser tedavisi i\u00e7in bekleme s\u00fcreleri konusunda di\u011fer \u00fclkelerin gerisinde kald\u0131"},"content":{"rendered":"

Son ara\u015ft\u0131rmalar, \u0130ngiltere’deki kanser hastalar\u0131n\u0131n radyoterapi veya kemoterapiye ba\u015flamak i\u00e7in benzer \u00fclkelere g\u00f6re yedi haftaya kadar daha uzun s\u00fcre bekledi\u011fini ortaya koydu.<\/p>\n

Uzmanlar, insanlar\u0131n hayatta kalma \u015fanslar\u0131n\u0131n tedavi i\u00e7in uzun s\u00fcre beklemelerinden etkilendi\u011fi konusunda uyar\u0131rken, bu \u00e7arp\u0131c\u0131 bulgular \u0130ngiltere’nin di\u011fer \u00fclkelerin ne kadar gerisinde kald\u0131\u011f\u0131n\u0131n da \u00e7arp\u0131c\u0131 bir kan\u0131t\u0131 oldu.<\/p>\n

University College London’dan uzmanlar, t\u00fcr\u00fcn\u00fcn ilk \u00f6rne\u011fi olan bu ara\u015ft\u0131rmada, 2012-2017 y\u0131llar\u0131 aras\u0131nda kar\u015f\u0131la\u015ft\u0131r\u0131labilir d\u00f6rt \u00fclkede te\u015fhis konulan 780.000’den fazla kanser hastas\u0131n\u0131n verilerini analiz etti: Avustralya, Kanada, Norve\u00e7 ve \u0130ngiltere.<\/p>

\"\"<\/a><\/div>\n

\u00c7al\u0131\u015fmaya \u00f6zofagus, mide, kolon, rektum, karaci\u011fer, pankreas, akci\u011fer ve yumurtal\u0131k kanseri olmak \u00fczere sekiz kanser t\u00fcr\u00fc dahil edildi.<\/p>\n

Lancet Oncology dergisinde yay\u0131nlanan iki \u00e7al\u0131\u015fma, \u00fc\u00e7 k\u0131tadaki \u00fclkelerde sekiz kanser t\u00fcr\u00fcne y\u00f6nelik tedavi farkl\u0131l\u0131klar\u0131n\u0131 inceleyen ilk \u00e7al\u0131\u015fma oldu. Ara\u015ft\u0131rma, en uzun bekleyenlerin \u0130ngiltere’deki hastalar oldu\u011funu ortaya koydu.<\/p>\n

Guardian<\/a>\u2019\u0131n haberine g\u00f6re; Kemoterapiye ba\u015flamak i\u00e7in ortalama s\u00fcre \u0130ngiltere’de 48, Kuzey \u0130rlanda’da 57, Galler’de 58 ve \u0130sko\u00e7ya’da 65 g\u00fcnd\u00fc. En k\u0131sa s\u00fcre ise Norve\u00e7’te 39 g\u00fcnd\u00fc.<\/strong><\/p>\n

Radyoterapide ise Birle\u015fik Krall\u0131k’\u0131n durumu daha da k\u00f6t\u00fcyd\u00fc. Kuzey \u0130rlanda’da tedavinin ba\u015flamas\u0131 ortalama 53 g\u00fcn, \u0130ngiltere’de 63, \u0130sko\u00e7ya’da 79 ve Galler’de 81 g\u00fcn s\u00fcrd\u00fc.<\/p>\n

En iyi sicile sahip olan Kanada’n\u0131n Newfoundland eyaletinde ortalama bekleme s\u00fcresi 42 g\u00fcnd\u00fc. Newfoundland ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda, Kuzey \u0130rlanda’da radyoterapi i\u00e7in bekleme s\u00fcresi 11 g\u00fcn daha uzundu. \u0130ngiltere’de bu s\u00fcre \u00fc\u00e7 hafta, \u0130sko\u00e7ya ve Galler’de ise yedi hafta daha uzundu.<\/p>\n

Ara\u015ft\u0131rma ayr\u0131ca \u0130ngiltere’de kanserli ki\u015filerin daha d\u00fc\u015f\u00fck bir oran\u0131na kemoterapi ve radyoterapi verildi\u011fini ortaya koydu. \u00dclkede yumurtal\u0131k kanseri hastalar\u0131n\u0131n %59’u kemoterapi al\u0131rken, bu oran Kanada’da %67, Norve\u00e7’te %72 ve Avustralya’da %73. Ayn\u0131 durum pankreas kanseri hastalar\u0131 i\u00e7in de ge\u00e7erli: \u0130ngiltere’de bu oran %27 iken Kanada’da %41, Norve\u00e7’te %44 ve Avustralya’da %47.<\/p>\n

\u00d6zellikle \u0130ngiltere’de ya\u015fl\u0131 hastalar\u0131n kemoterapi ve radyoterapi tedavisi alma olas\u0131l\u0131\u011f\u0131 en d\u00fc\u015f\u00fck orana sahip. \u00d6rne\u011fin, 85 ya\u015f ve \u00fczeri \u0130ngiliz hastalar\u0131n %2’si kemoterapi al\u0131rken, bu oran Avustralya’da %8, Ontario’da %14.<\/p>\n

T\u00fcm hastalar\u0131n ihtiyac\u0131 olmasa da kemoterapi ve radyoterapi \u00f6nemli tedavi se\u00e7enekleri aras\u0131nda. Uluslararas\u0131 Kanser K\u0131yaslama Ortakl\u0131\u011f\u0131 ara\u015ft\u0131rmas\u0131na g\u00f6re, kanserden sa\u011fkal\u0131m oranlar\u0131 daha iyi olan \u00fclkelerde kemoterapi ve radyoterapi daha fazla kullan\u0131l\u0131yor ve tedavi i\u00e7in bekleme s\u00fcreleri daha k\u0131sa.<\/p>\n

\u0130ki ara\u015ft\u0131rmay\u0131 da finanse eden Cancer Research UK, tedaviye ba\u015flamadaki gecikmelerin k\u0131smen \u0130ngiltere h\u00fck\u00fcmetinin son y\u0131llarda kanser konusunda uzun vadeli planlama yapmamas\u0131n\u0131n bir sonucu oldu\u011funu s\u00f6yledi. Finansmanla desteklenen sa\u011flam kanser stratejilerine sahip \u00fclkelerde hayatta kalma oranlar\u0131nda daha iyi geli\u015fmeler g\u00f6r\u00fcld\u00fc.<\/p>\n

 <\/p>\n

\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

Son ara\u015ft\u0131rmalar, \u0130ngiltere’deki kanser hastalar\u0131n\u0131n radyoterapi veya kemoterapiye ba\u015flamak i\u00e7in benzer \u00fclkelere g\u00f6re yedi haftaya kadar daha uzun s\u00fcre bekledi\u011fini ortaya koydu. Uzmanlar, insanlar\u0131n hayatta kalma \u015fanslar\u0131n\u0131n tedavi i\u00e7in uzun s\u00fcre beklemelerinden etkilendi\u011fi konusunda uyar\u0131rken, bu \u00e7arp\u0131c\u0131 bulgular \u0130ngiltere’nin di\u011fer \u00fclkelerin ne kadar gerisinde kald\u0131\u011f\u0131n\u0131n da \u00e7arp\u0131c\u0131 bir kan\u0131t\u0131 oldu. University College London’dan uzmanlar, t\u00fcr\u00fcn\u00fcn ilk \u00f6rne\u011fi olan bu ara\u015ft\u0131rmada, 2012-2017 y\u0131llar\u0131 aras\u0131nda kar\u015f\u0131la\u015ft\u0131r\u0131labilir d\u00f6rt \u00fclkede te\u015fhis konulan 780.000’den fazla kanser hastas\u0131n\u0131n verilerini analiz etti: Avustralya, Kanada, Norve\u00e7 ve \u0130ngiltere. \u00c7al\u0131\u015fmaya \u00f6zofagus, mide, kolon, rektum, karaci\u011fer, pankreas, akci\u011fer ve yumurtal\u0131k kanseri olmak \u00fczere sekiz kanser t\u00fcr\u00fc dahil edildi. Lancet Oncology […]<\/p>\n","protected":false},"author":1,"featured_media":23718,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-23717","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/23717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=23717"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/23717\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media\/23718"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=23717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=23717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=23717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}